HenryLGomezMD

PubMed

• 17 citations
  Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma.
  Carlos A. Castaneda, Miluska Castillo, Carlos A. Torres-Cabala, Luis A. Bernabe, Sandro Casavilca, Valeria Villegas, J. Sanchez, M. de la Cruz, Jorge Dunstan, Jose M. ...> ;Clinical & Translational Oncology. 2019 Sep 11
• Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
  Ribi, K.,Luo, W.,Colleoni, M.,Karlsson, P.,Chirgwin, J.,Aebi, S.,Jerusalem, G.,Neven, P.,Di Lauro, V.,Gomez, H. L.,Ruhstaller, T.,Abdi, E.,Biganzoli, L.,Müller, B.,Bar...> ;Br. J. Cancer. 2019 Apr 11
• 9 citations
  Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America.
  Joseph A. Pinto, Cesar H. Saravia, Claudio Flores, Jhajaira M. Araujo, David Martínez, Luis J. Schwarz, Alberto Casas, Leny Bravo, Jenny Zavaleta, Brigitte Chuima, Hob...> ;Ecancermedicalscience. 2019 Jan 22
• 79 citations
  Correction: RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: Therapeutic cooperation between MEK and PD-...
  Sherene Loi, Sathana Dushyanthen, Paul A. Beavis, Roberto Salgado, Carsten Denkert, Peter Savas, Susan E. Combs, David L. Rimm, Jennifer M. Giltnane, Monica V. Estrada...> ;Clinical Cancer Research. 2019 Feb 15
• 2 citations
  Implementation of Computerized Physician Order Entry for Chemotherapy: A Latin American Experience
  Fernando Valencia, Rossana Ruiz, Silvia P. Neciosup, Luis Mas, Karina Aliaga, Flor Huaman, Jenny Ruiz, Edinson Vasquez, Noel Llacctahuaman, Robert Pedraza, Missael Paz...> ;JCO Clinical Cancer Informatics. 2018 Dec 10
• Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.
  Moore, HCF.,Unger, J. M.,Phillips, K. A.,Boyle, F.,Hitre, E.,Moseley, A.,Porter, D. J.,Francis, P. A.,Goldstein, L. J.,Gomez, H. L.,Vallejos, C. S.,Partridge, A. H.,Da...> ;J. Natl. Cancer Inst.. 2018 Oct 30
• 6 citations
  Breast cancer subtype and survival among Indigenous American women in Peru.
  Lizeth I. Tamayo, Tatiana Vidaurre, Jeannie Navarro Vásquez, Sandro Casavilca, Jessica Ivonne Aramburu Palomino, Monica Calderon, Julio Abugattas, Henry L. Gomez, Carl...> ;Plos One. 2018 Sep 5
• 6 citations
  Critical review of axillary recurrence in early breast cancer
  Carlos A. Castaneda, Pamela Rebaza, Miluska Castillo, Henry L. Gomez, Miguel De La Cruz, Gabriela Calderon, Jorge Dunstan, Jose M. Cotrina, Julio Abugattas, Tatiana Vi...> ;Critical Reviews in Oncology/hematology. 2018 Sep 1
• Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key.
  Rabanal, C.,Ruiz, R.,Neciosup, S.,Gomez, H.> ;World J Clin Oncol. 2018 Jan 02
• 34 citations
  RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Nega...
  José Baselga, Claudio Zamagni, Patricia Gomez, Begoña Bermejo, Shigenori E. Nagai, Bohuslav Melichar, Arlene Chan, László Mangel, Jonas Bergh, Frederico Costa, Henry L...> ;Clinical Breast Cancer. 2017 Dec 1
• Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute.
  Ruiz, R.,Morante, Z.,Mantilla, R.,Mas, L.,Casanova, L.,Gomez, H. L.> ;An Bras Dermatol. 2017 Nov 23
• 71 citations
  Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Th...
  Poornima Saha, Meredith M. Regan, Olivia Pagani, Prudence A. Francis, Barbara Walley, Karin Ribi, Jürg Bernhard, Weixiu Luo, Henry L. Gomez, Harold J. Burstein, Vani P...> ;Journal of Clinical Oncology. 2017 Jun 27
• 40 citations
  Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America
  Carlos A. Castaneda, Carlos A. Torres-Cabala, Miluska Castillo, Valeria Villegas, Sandro Casavilca, Luis Cano, J. Sanchez, Jorge Dunstan, Gabriela Calderon, M. de la C...> ;Clinical & Translational Oncology. 2017 Jun 2
• 174 citations
  Anthracyclines in early breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
  Joanne L. Blum, Patrick J. Flynn, Greg Yothers, Lina Asmar, Charles E. Geyer, Samuel A. Jacobs, Nicholas J. Robert, Judith O. Hopkins, Joyce O'Shaughnessy, Chau T. Dan...> ;Journal of Clinical Oncology. 2017 Apr 11
• Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.
  Colleoni M, Gray KP, Gelber S, Láng I, Thürlimann B, Gianni L, Abdi EA, Gomez HL, Linderholm BK, Puglisi F, Tondini C, Kralidis E, Eniu A, Cagossi K, Rauch D, Chirgwin...> ;J. Clin. Oncol.. 2016-10-01
• 114 citations
  Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast...
  Meredith M. Regan, Prudence A. Francis, Olivia Pagani, Gini F. Fleming, Barbara Walley, Giuseppe Viale, Marco Colleoni, István Láng, Henry L. Gomez, Carlo Tondini, Gra...> ;Journal of Clinical Oncology. 2016 Sep 27
• Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib ...
  Piccart-Gebhart, M.,Holmes, E.,Baselga, J.,de Azambuja, E.,Dueck, A. C.,Viale, G.,Zujewski, J. A.,Goldhirsch, A.,Armour, A.,Pritchard, K. I.,McCullough, A. E.,Dolci, S...> ;J. Clin. Oncol.. 2015 Nov 26
• Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer.
  Araujo, J. M.,Prado, A.,Cardenas, N. K.,Zaharia, M.,Dyer, R.,Doimi, F.,Bravo, L.,Pinillos, L.,Morante, Z.,Aguilar, A.,Mas, L. A.,Gomez, H. L.,Vallejos, C. S.,Rolfo, C....> ;Oncotarget. 1900 Jan 01
• A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease.
  Pinto, J. A.,Araujo, J.,Cardenas, N. K.,Morante, Z.,Doimi, F.,Vidaurre, T.,Balko, J. M.,Gomez, H. L.> ;NPJ Genom Med. 2016 Feb 03
• PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers.
  Castaneda CA, Lopez-Ilasaca M, Pinto JA, Chirinos-Arias M, Doimi F, Neciosup SP, Rojas KI, Vidaurre T, Balko JM, Arteaga CL, Gomez HL> ;Hematol Oncol Stem Cell Ther. 2014-12-01
• Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.
  Guan Z, Xu B, DeSilvio ML, Shen Z, Arpornwirat W, Tong Z, Lorvidhaya V, Jiang Z, Yang J, Makhson A, Leung WL, Russo MW, Newstat B, Wang L, Chen G, Oliva C, Gomez H> ;J. Clin. Oncol.. 2013-06-01
• 1 citations
  WITHDRAWN: Addition of amifostine to CHOP regimen significantly reduced toxicity in patients with aggressive non-Hodgkin's lymphoma without affecting the long term sur...
  Henry L. Gomez> ;Hematology/oncology and Stem Cell Therapy. 2013 Mar 29
• 1 citations
  Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering lo...
  Henry L. Gomez, C. Samanez, Frank Campana, Silvia P. Neciosup, Luis Vera, Luis Casanova, Jorge Leon, Claudio Flores, Fernando Hurtado de Mendoza, Carlos A. Casteñeda, ...> ;Hematology/oncology and Stem Cell Therapy. 2012 Jul 1
• First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of ...
  Vitolo U, Chiappella A, Ferreri AJM, Martelli M, Baldi I, Balzarotti M, Bottelli C, Conconi A, Gomez H, Lopez-Guillermo A, Martinelli G, Merli F, Novero D, Orsucci L, ...> ;J. Clin. Oncol.. 2011-07-10
• Risk factors for outcome in Hispanic patients with breast cancer with central nervous system (CNS) metastases.
  Schwarz LJ, Vidaurre T, Neciosup SP, Pinto JA, Ferreyros G, Gomez H> ;J. Clin. Oncol.. 2011-05-20
• Join now to see all